4.8 Editorial Material

14-3-3ζ Turns TGF-β to the Dark Side

期刊

CANCER CELL
卷 27, 期 2, 页码 151-153

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2015.01.005

关键词

-

向作者/读者索取更多资源

TGF-beta/SMAD signaling has long been known to exhibit a dual role in cancer, questioning what determines its context-dependent functions. In this issue of Cancer Cell, Xu and colleagues describe a critical role of the adaptor protein 14-3-3 zeta in modulating SMAD activities by changing its interaction partners during breast cancer progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

Christian David Schmid, Victor Olsavszky, Manuel Reinhart, Vanessa Weyer, Felix A. Trogisch, Carsten Sticht, Manuel Winkler, Sina W. Kurschner, Johannes Hoffmann, Roxana Ola, Theresa Staniczek, Joerg Heineke, Beate K. Straub, Jens Mittler, Kai Schledzewski, Peter ten Dijke, Karsten Richter, Steven Dooley, Cyrill Geraud, Sergij Goerdt, Philipp-Sebastian Koch

Summary: This study established an HHT mouse model with liver vascular malformations and investigated the role of ALK1 signaling in liver vessel formation and metabolic function. The results showed that hepatic endothelial ALK1 signaling protects from development of vascular malformations and preserves organ-specific endothelial differentiation and angiocrine signaling.

HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial-mesenchymal transition of breast cancer cells

Jing Zhang, Maarten van Dinther, Midory Thorikay, Babak Mousavi Gourabi, Boudewijn P. T. Kruithof, Peter ten Dijke

Summary: Ubiquitin-specific protease (USP)19 is a deubiquitinating enzyme that regulates protein stability and function, with its alternative splicing resulting in two major variants localized to the endoplasmic reticulum and cytoplasm. USP19-CY promotes TGF-beta signaling by interacting with the TGF-beta type I receptor and preventing its degradation at the plasma membrane, while USP19-ER sequesters the receptor in the ER and inhibits TGF-beta/SMAD signaling. Increased USP19-CY expression is associated with poor prognosis and higher levels in breast cancer tissues, where it enhances epithelial-mesenchymal transition and cell migration. Modulating USP19 splicing or deubiquitinating activity may hold therapeutic potential for breast cancer.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Biochemistry & Molecular Biology

ST3GAL5-catalyzed gangliosides inhibit TGF-β-induced epithelial-mesenchymal transition via TβRI degradation

Jing Zhang, Gerard van Der Zon, Jin Ma, Hailiang Mei, Birol Cabukusta, Cedrick C. Agaser, Katarina Madunic, Manfred Wuhrer, Tao Zhang, Peter ten Dijke

Summary: Epithelial-mesenchymal transition (EMT) is important in cancer cell metastasis. The abundance of glycosphingolipids (GSLs), specifically ganglioside subtypes, decreases during TGF-beta-induced EMT. Inhibition of UDP-glucose ceramide glucosyltransferase (UGCG), the enzyme responsible for GSL biosynthesis, promotes TGF-beta signaling and EMT. ST3GAL5-synthesized a-series gangliosides inhibit TGF-beta signaling and EMT in lung cancer cells.

EMBO JOURNAL (2023)

Letter Oncology

Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence

Yang Hao, Sen Ma, Zili Gu, Alireza Haghparast, Timo Schomann, Zhenfeng Yu, Yuanyuan He, Xiaoxv Dong, Luis J. Cruz, Peter ten Dijke

CANCER COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation

Chuannan Fan, Qian Wang, Thomas B. Kuipers, Davy Cats, Prasanna Vasudevan Iyengar, Sophie C. Hagenaars, Wilma E. Mesker, Peter Devilee, Rob A. E. M. Tollenaar, Hailiang Mei, Peter ten Dijke

Summary: In this study, the researchers found that the long noncoding RNA LITATS1 functions as an epithelial gatekeeper and inhibits epithelial-mesenchymal transition in breast and non-small cell lung cancer cells. They also discovered that LITATS1 enhances the degradation of the TGF-beta type I receptor, leading to the attenuation of TGF-beta/SMAD signaling and EMT.

EMBO JOURNAL (2023)

Article Oncology

Differential optineurin expression controls TGFβ signaling and is a key determinant for metastasis of triple negative breast cancer

Sijia Liu, Maarten van Dinther, Sophie C. Hagenaars, Yuanzhuo Gu, Thomas B. Kuipers, Hailiang Mei, Maria Catalina Gomez-Puerto, Wilma E. Mesker, Peter ten Dijke

Summary: Triple-negative breast cancer (TNBC) is a challenging subtype due to its aggressive nature and low response to current therapies. Understanding TNBC metastasis may lead to better diagnosis and treatment options. In this study, OPTN was found to play a surprising role in inhibiting TNBC metastasis by suppressing the TGF beta signaling pathway. These findings suggest that OPTN may be a potential target for suppressing TNBC metastasis.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Biochemistry & Molecular Biology

TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth

Dieuwke L. Marvin, Jelmer Dijkstra, Rabia M. Zulfiqar, Michiel Vermeulen, Peter ten Dijke, Laila Ritsma

Summary: Melanoma patients with liver metastasis have a poor prognosis. The cytokine Transforming Growth Factor beta (TGF-beta) plays a role in melanoma cells and acts on cells in the liver. We hypothesized that this cytokine influences the metastatic outgrowth of melanoma in liver. To investigate this, we generated a model to turn on and off TGF-beta signaling in the B16F10 melanoma cells, and found that TGF-beta activation repressed cell growth and migration in vitro, while it increased outgrowth in liver in vivo.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Multidisciplinary

Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation

Zili Gu, Yang Hao, Timo Schomann, Ferry Ossendorp, Peter ten Dijke, Luis J. Cruz

Summary: The cGAS-STING pathway acts as a bridge between innate and adaptive immunity, making it a promising approach for anti-cancer immunotherapy. Chemotherapy-induced DNA damage can directly induce dendritic cell maturation and recruitment, which synergizes with STING activation to enhance anti-tumor effects. In this study, liposomes encapsulating oxaliplatin were developed and combined with a STING agonist to treat colorectal cancer, resulting in complete remission of tumors. Mechanistic studies showed that this treatment resulted in the recruitment of infiltrating CD8 and CD4 T cells, reduction of suppressive Treg cells, and a shift in the phenotype of tumor-associated suppressive macrophages, leading to an immune-stimulating environment.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Biochemistry & Molecular Biology

The lncRNA LETS1 promotes TGF-β-induced EMT and cancer cell migration by transcriptionally activating a TβR1-stabilizing mechanism

Chuannan Fan, Roman Gonzalez-Prieto, Thomas B. Kuipers, Alfred C. O. Vertegaal, Peter A. van Veelen, Hailiang Mei, Peter ten Dijke

Summary: We identified an unannotated nuclear long noncoding RNA (lncRNA), LETS1, which is not only increased but also perpetuated by TGF-beta signaling. Loss of LETS1 attenuated TGF-beta-induced EMT and migration in breast and lung cancer cells in vitro and extravasation of the cells in a zebrafish xenograft model. LETS1 potentiates TGF-beta-SMAD signaling by stabilizing cell surface T beta RI, thereby forming a positive feedback loop.

SCIENCE SIGNALING (2023)

Article Oncology

Opposing roles for ADAMTS2 and ADAMTS14 in myofibroblast differentiation and function

Edward P. Carter, Kubra K. Yoneten, Nuria Gavara, Eleanor J. Tyler, Valentine Gauthier, Elizabeth R. Murray, Peter ten Dijke, Angus J. Cameron, Oliver Pearce, Richard P. Grose

Summary: The crosstalk between cancer and stellate cells is crucial in the progression of pancreatic cancer. Through transcriptomic analysis, the study identified the specific expression of enzymes ADAMTS2 and ADAMTS14 in stellate cells, which regulate myofibroblast differentiation by modulating the availability of transforming growth factor beta.

JOURNAL OF PATHOLOGY (2023)

Article Multidisciplinary Sciences

CD44 acts as a coreceptor for cell- specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimic

Maarten van Dinther, Kyle T. Cunningham, Shashi Prakash Singh, Madeleine P. J. White, Tiffany Campion, Claire Ciancia, Peter A. van Veelen, Arnoud H. de Ru, Roman Gonzalez-Prieto, Ananya Mukundan, Chang- Hyeock Byeon, Sophia R. Staggers, Cynthia S. Hinck, Andrew P. Hinck, Peter ten Dijke, Rick M. Maizels

Summary: This study investigates how the murine intestinal helminth, Heligmosomoides polygyrus, evades the host immune system through the release of an immunosuppressive protein called TGM1. The researchers found that TGM1 binds to the cell surface protein CD44, increasing the potency and specificity of TGF-beta signaling in mammalian cells.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Multidisciplinary Sciences

Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells

Yuanzhuo Gu, Zhengkui Zhang, Marcel G. M. Camps, Ferry Ossendorp, Ruud H. Wijdeven, Peter ten Dijke

Summary: The genetic circuits allowing cancer cells to evade immune killing through epithelial mesenchymal plasticity are poorly understood. This study found that mesenchymal-like pancreatic cancer cells were more resistant to cytotoxic T lymphocyte (CTL)-mediated killing than epithelial-like cells. Genome-wide CRISPR screens were used to identify the molecular mechanisms underlying this difference. It was discovered that Mes-specific regulators such as Egfr and Mfge8 facilitate immune escape from CD8(+) T cells by inhibiting their proliferation and the production of immune signaling molecules.

SCIENCE ADVANCES (2023)

Review Medicine, Research & Experimental

Lipid-based nanoparticles as drug delivery systems for cancer immunotherapy

Yang Hao, Zhonghao Ji, Hengzong Zhou, Dongrun Wu, Zili Gu, Dongxu Wang, Peter ten Dijke

Summary: Immune checkpoint inhibitors (ICIs) have shown remarkable success in cancer treatment. However, in cancer patients without sufficient antitumor immunity, blocking the negative signals elicited by immune checkpoints is ineffective. Stimulating immune activation-related pathways and utilizing nanotechnology for targeted delivery show promising potential for enhancing cancer immunotherapy. This review discusses the latest developments in lipid-based nanoparticles (lipid-NPs) for cancer immuno-oncology therapy, focusing on their characteristics, advantages, and potential to enhance STING agonist therapy.

MEDCOMM (2023)

Article Oncology

Intertumoral Differences Dictate the Outcome of TGF-beta Blockade on the Efficacy of Viro-Immunotherapy

Christianne Groeneveldt, Jurriaan Q. Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen, Camilla Labrie, Diana J. M. van den Wollenberg, Rob C. Hoeben, Sjoerd H. van der Burg, Peter ten Dijke, Lukas J. A. C. Hawinkels, Thorbald van Hall, Nadine van Montfoort

Summary: The absence of T cells in the tumor microenvironment is a barrier to cancer immunotherapy efficacy. Oncolytic viruses, such as reovirus type 3 Dearing (Reo), can recruit CD8(+) T cells to the tumor and enhance immunotherapeutic strategies. However, TGF-beta signaling might hinder the effectiveness of Reo&CD3-bsAb therapy due to its immunoinhibitory characteristics.

CANCER RESEARCH COMMUNICATIONS (2023)

Review Immunology

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy

Yuanzhuo Gu, Zhengkui Zhang, Peter ten Dijke

Summary: Immune checkpoint blockade (ICB) therapy is a powerful option for cancer treatment, but many patients are resistant to this treatment. Tumor epithelial-to-mesenchymal plasticity (EMP) plays a critical role in immune escape and ICB resistance in cancer. This review summarizes the role of tumor EMP in ICB resistance and discusses strategies to modulate it for better treatment outcomes.

CELLULAR & MOLECULAR IMMUNOLOGY (2023)

暂无数据